Blockade of a Novel Neuropeptide Receptor System, BigLEN-GPR171, Reduces Adverse Effects of Prolonged Morphine Administration
Antinociceptive effects of novel histamine H3R and H4R receptor antagonists and their influence on morphine analgesia of neuropathic pain in the mouse.
Tags: analgesic, Arymo ER®, central nervous system, Duramorph®, Infumorph P/F®, Kadian®, MorphaBond ER®, morphine metabolite, MS Contin®, opioid, pain
BASi Method Number SAP.1538
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
